A spectacularly toxic form of damage, the interstrand crosslink (ICL), arises when two strands of duplex DNA become covalently linked [1]. The cellular response to ICLs is of great interest because several antitumour drugs, including platinum agents and mitomycin C, kill cancer cells by inducing ICLs [2, 3]. More recently it has become apparent that metabolites continually burden cells with ICLs, which must be removed for cells to maintain function and viability. The importance of efficient ICL repair in development and health is illustrated by the clinical features of a devastating inherited syndrome, Fanconi anemia (FA), which is thought to be the result of defective ICL repair [4]. FA patients suffer from bone marrow failure, leukaemia, and solid malignancies. While the endogenous DNA-crosslinking agent, or agents, responsible for the damage that lies unrepaired in the cells of FA patients are unknown, suspects include the common metabolites formaldehyde and acetaldehyde (including that derived from ingested alcohol) and oxidised lipid species [5-7]. The machinery available to repair ICLs has expanded markedly through evolution. Both Escherichia coli and yeasts almost exclusively rely on a modified form of nucleotide excision repair (NER) [1, 8], a cut-and-paste pathway that is best known for its ability to remove UVlight-induced DNA photodimers (whose defects result in another human syndrome, Xeroderma pigmentosum [XP]). The details of how modified NER removes ICLs remain obscure and merit further investigation. Metazoans, meanwhile, have developed additional pathways for ICL repair-most significantly, an 'FA pathway' [4]. The functional characterization of genes and factors defective in FA patients (22 genes to date) have revealed a repair pathway that operates during DNA replication and possibly elsewhere in the cell cycle (although this aspect has yet to be explored systematically). Although how the FA pathway coordinates ICL repair is still subject to intense study, it appears to orchestrate initial responses to ICLs, some steps of the nucleolytic processing of ICLs, and the subsequent resolution of the incised intermediates through the sequential action of translesion-synthesis polymerases and homologous recombination reactions [9]. For mammalian cells, it is not clear whether there is a genetic or functional relationship between the NER and FA pathways in response to ICLs. Here, Mulderrig and Garaycoechea show that while both the FA and NER pathways both play important roles in response to ICLs, additional pathways also contribute to their repair [10]. At the heart of this uncertainty about the contributions of the FA and NER pathways to ICL repair is a dimeric endonuclease, XPF-ERCC1, required for both pathways and mutated in both FA (complementation group Q, FANCQ) and XP (complementation group F) [11, 12]. XPF-ERCC1 has received much attention, since it was realised several decades ago that XPF-ERCC1-deficient mammalian cells are exquisitely sensitive to ICL-inducing agents [13, 14], showing a sensit...